Atlas Trials

Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia

Clinical trial NCT01979601 · COMPLETED

Trial details

NCT number
NCT01979601
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2010-12-01
Primary completion
2011-11-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.